Sanofi (SNY) Treasury Shares (2009 - 2025)
Sanofi's (SNY) quarterly Treasury Shares came in at -$3.8 billion in Q1 2025, down 1057.11% year-over-year from $396.6 million in Q1 2024, and down 1076.34% quarter-over-quarter from -$322.7 million in Q4 2024.
Analysis
Sanofi (SNY) Treasury Shares (2009 - 2025) Analysis & Trends
Sanofi has disclosed Treasury Shares across 17 years of filings, most recently posting -$3.8 billion for Q1 2025.
- In Q1 2025, Treasury Shares fell 1057.11% year-over-year to -$3.8 billion; the TTM figure through Mar 2025 stood at -$3.8 billion (down 1057.11% YoY), while the FY2024 annual figure was -$326.9 million, up 49.04% from the prior year.
- Treasury Shares came in at -$3.8 billion for Q1 2025 at Sanofi, down from -$322.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of -$322.7 million in Q4 2024 to a low of -$980.1 million in Q4 2020.
- Average Treasury Shares over 5 years is -$507.7 million, with a median of -$417.3 million recorded in 2021.
- Year-over-year, Treasury Shares surged 57.63% in 2021 and sank 1057.11% in 2025.
- Over 5 years, Treasury Shares stood at -$437.0 million in 2021, then retreated by 16.03% to -$507.1 million in 2022, then fell by 25.83% to -$638.0 million in 2023, then jumped by 49.42% to -$322.7 million in 2024, then tumbled by 1076.34% to -$3.8 billion in 2025.
- Per Business Quant data, the three most recent Treasury Shares figures were -$3.8 billion in Q1 2025, -$322.7 million in Q4 2024, and -$331.7 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 711.62 Mn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 1.11 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -49.00 Mn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 3.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 880.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -3.80 Bn |
| Mar 31, 2025 | -3.80 Bn |
| Dec 31, 2024 | -322.72 Mn |
| Dec 31, 2024 | -322.72 Mn |
| Dec 31, 2024 | -322.72 Mn |
| Dec 31, 2024 | -322.72 Mn |
| Sep 30, 2024 | -331.66 Mn |
| Sep 30, 2024 | -331.66 Mn |
| Mar 31, 2024 | -328.08 Mn |
| Mar 31, 2024 | -328.08 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Sep 30, 2023 | -395.16 Mn |
| Sep 30, 2023 | -395.16 Mn |
| Jun 30, 2023 | -395.28 Mn |
| Jun 30, 2023 | -395.28 Mn |
| Mar 31, 2023 | -389.62 Mn |
| Mar 31, 2023 | -389.62 Mn |